Our proprietary novel technology platform is an advanced stem cell culture system – HPME® – High Performance Micro Environment. It replicates the 3-dimensional “home” in which stem cells naturally reside and proliferate. Our unique technology enables users to isolate and grow stem cells from a variety of sources including but not limited to adipose, bone marrow and umbilical cord blood/tissue.
OUR CORE NOVEL TECHNOLOGY PLATFORM IS AN ADVANCED STEM CELL CULTURE SYSTEM – HPME® – HIGH PERFORMANCE MICRO ENVIRONMENT. BM-HPME® REPLICATES THE 3-DIMENSIONAL “HOME” IN WHICH STEM CELLS NATURALLY RESIDE AND PROLIFERATE.
Stem cells grown in BM-HPME® remain small, proliferative and undifferentiated. Our unique technology enables users to isolate and grow stem cells and other difficult to culture cells from a variety of sources including but not limited to adipose, bone marrow and umbilical cord blood/tissue and cancer cells.
The HPME® architecture also has enabled us to isolate and expand multi-potent stem cells from human umbilical cord blood (hUCB-SCs), a non-controversial and plentiful resource. This patent-pending process produces non-differentiated stem cells capable of producing tissues from all 3 developmental germ layers.
In pursuing proof-of-concept, we have documented how our hUCB-SCs, when implanted into experimental animals, produce discrete bundles of various human tissues, including muscle, nerve, bone, adipose and glandular tissues. StemBioSys will explore the clinical effects of the trophic hormones, mediators and growth factors produced by and associated with these stem cells.